Eupnoos raises €443K Seed round
3 March 2025· London, United Kingdom· health, ai, biotech, b2b, pure_software
The funding is designated for advancing the company's smartphone-based lung monitoring technology through Phase 1 clinical trials.
Investors
LeadSFC Capital
Also participating
MedTech InnovatorInnovate UKMilltrust InternationalKunsen
About Eupnoos
Stage
Seed
Headquarters
London, United Kingdom
Founded
2020
Team Size
1–5
Sectors
healthaibiotechb2bpure_software
Source: https://pitchbook.com/profiles/company/465228-56#funding